Dakota Wealth Management Sells 28,152 Shares of Tempus AI, Inc. (NASDAQ:TEM)

Dakota Wealth Management lessened its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 46.4% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 32,516 shares of the company's stock after selling 28,152 shares during the period. Dakota Wealth Management's holdings in Tempus AI were worth $1,569,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Bank of New York Mellon Corp acquired a new stake in shares of Tempus AI in the fourth quarter valued at approximately $1,615,000. US Bancorp DE bought a new position in Tempus AI in the 4th quarter valued at $80,000. Victory Capital Management Inc. acquired a new position in shares of Tempus AI during the fourth quarter valued at $216,000. Raymond James Financial Inc. bought a new position in Tempus AI in the fourth quarter valued at about $3,757,000. Finally, Farther Finance Advisors LLC bought a new position in Tempus AI in the fourth quarter valued at about $34,000. Institutional investors and hedge funds own 24.22% of the company's stock.

Insider Activity

In related news, Director Jennifer A. Doudna sold 625 shares of the business's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $62.52, for a total value of $39,075.00. Following the sale, the director directly owned 26,554 shares of the company's stock, valued at approximately $1,660,156.08. The trade was a 2.30% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Erik Phelps sold 51,317 shares of the company's stock in a transaction on Monday, June 16th. The stock was sold at an average price of $72.56, for a total transaction of $3,723,561.52. Following the completion of the transaction, the executive vice president directly owned 97,779 shares of the company's stock, valued at approximately $7,094,844.24. The trade was a 34.42% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 612,522 shares of company stock worth $41,600,238. Corporate insiders own 27.60% of the company's stock.

Analyst Ratings Changes

A number of research firms have issued reports on TEM. Needham & Company LLC restated a "buy" rating and set a $70.00 target price on shares of Tempus AI in a research report on Wednesday, May 7th. Guggenheim lifted their target price on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a report on Monday, June 30th. Morgan Stanley upped their target price on shares of Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Piper Sandler raised their price target on Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a research report on Thursday, May 15th. Finally, BTIG Research initiated coverage on Tempus AI in a research note on Monday, April 21st. They issued a "buy" rating and a $60.00 target price on the stock. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $65.09.

Tempus AI Trading Up 0.5%

TEM stock traded up $0.33 during midday trading on Friday, hitting $60.98. 8,333,428 shares of the company's stock were exchanged, compared to its average volume of 7,698,202. Tempus AI, Inc. has a one year low of $31.36 and a one year high of $91.45. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.56 and a current ratio of 1.71. The company has a market cap of $10.56 billion and a PE ratio of -7.82. The stock's fifty day moving average price is $63.06 and its 200-day moving average price is $55.65.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.03. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The company had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. The business's quarterly revenue was up 75.4% on a year-over-year basis. Research analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.